{
  "retracted": false,
  "timestamp": 1510617600000,
  "updates": [
    {
      "timestamp": 1585482430448,
      "identifier": {
        "doi": "10.1007/s10147-017-1212-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10147-015-0943-z"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)"
}
